Papa John's International Inc (NASDAQ:PZZA) shares gained 5% to $43.05 on Monday following a report that the pizza maker is in advanced discussions with TriArtisan Capital to be taken private at $65 per share, according to ABC Money UK, which cited people familiar with the talks.
The potential acquisition price would value Papa John's at $2.7 billion.
Tesla Inc (NASDAQ:TSLA) shares added almost 4% after it was announced that the head of its divisive Cybertruck unit, Siddhant Awasthi, is departing the company after eight years.
Awasthi began his career at Tesla as an intern in 2017 and eventually led the Cybertruck program from engineering through mass production. In July 2025, he also assumed responsibility for the Model 3 program, overseeing product strategy, quality improvements, and supply chain management.
Metsera (NASDAQ:MTSR) announced that it has entered into an amended merger agreement with Pfizer Inc (NYSE:PFE, ETR:PFE), under which Pfizer will acquire the biotech company for up to $86.25 per share, valuing it at about $10 billion.
The offer consists of $65.60 per share in cash and a contingent value right (CVR) for additional payments of up to $20.65 per share based on clinical and regulatory milestones.
TreeHouse Foods Inc (NYSE: THS) shares surged 23% to $23.45 on Monday after the packaged food maker agreed to be taken private by European investment group Investindustrial for $22.50 per share in cash, or a total enterprise value of $2.9 billion.
The transaction is expected to close in the first quarter of 2026.
Monday.com Ltd (NASDAQ: MNDY) reported better than expected financial results for its third quarter 2025 but provided revenue guidance that fell short of the Wall Street forecast.
The project management software provider posted an adjusted profit in the quarter of $1.16 a share, up 36% from a year ago, on revenue that rose 26% year over year to $316.9 million.
eToro Group Ltd (NASDAQ: ETOR) on Monday reported better than expected earnings for its third quarter 2025, boosted by robust user growth and diversified revenue streams.
The stock and crypto trading platform posted an adjusted profit of $0.60 per share in the quarter, surpassing the analyst consensus estimate of $0.56, according to data compiled by LSEG.
NanoViricides (NYSE-A:NNVC) announced that it has received approval to begin its Phase II Clinical Trial of NV-387 for the Treatment of MPox by the Regulatory Agency ACOREP of the Democratic Republic of Congo (DRC).
The clinical stage biotechnology company said the proposed Phase II clinical trial to evaluate safety and effectiveness of NV-387 for the treatment of patients with MPox disease caused by hMPXV infection is now cleared to proceed subject to filing of certain documents.
HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) announced that it produced 289 Bitcoin in October 2025, 8% more than the previous month and an increase of 147% year over year.
The multinational digital infrastructure company said its average daily production in October was 9.3 Bitcoin, while its hashrate averaged 21.9 Exahash per Second (EH/s) during the month.
AtaiBeckley NV (NASDAQ:ATAI, ETR:9VC) has unveiled positive topline results from the open-label extension (OLE) study of its Phase 2b clinical trial evaluating BPL-003 in patients with treatment-resistant depression (TRD).
The company said that a 12 mg dose of BPL-003 (mebufotenin benzoate nasal spray) administered eight weeks after an initial 0.3 mg, 8 mg, or 12 mg dose produced additional rapid and clinically meaningful antidepressant effects that were sustained for up to eight weeks.
Shares in Strategic Minerals PLC (AIM:SML, OTC:SMCDF) climbed 8% to 1.86p after the company reported updated assay results from its Redmoor Tungsten-Tin-Copper Project in Cornwall, showing higher-than-expected grades of tin and tungsten.
The new data from drill hole CRD033 confirmed several high-grade intersections, including 2 metres at 4.04% tungsten trioxide equivalent (WO₃ Eq.) and 9.35 metres at 0.76% WO₃ Eq., demonstrating strong mineralisation across multiple veins.
Shares in MedPal AI jumped 10% to 7.94p after the digital health and artificial intelligence company confirmed formal approval from the Norfolk and Waveney Integrated Care Board (ICB) for the transfer of an NHS Pharmacy Contract from Universal Pharmacy, completing its acquisition announced in October.
The move marks MedPal AI’s first NHS contract, granting subsidiary MedPal Limited authorisation to provide regulated pharmacy services nationwide.
Shares in Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) climbed 7.3% to 19p after the company updated the mineral resource estimate at its Phalaborwa project in South Africa to include yttrium, a heavy rare earth element (REE) currently under Chinese export controls.
The revision confirms Phalaborwa as a potential near-term source of both medium and heavy REE, including dysprosium, terbium, samarium, europium, gadolinium and yttrium, as well as critical light REE such as neodymium and praseodymium.